Bachem Holding AG (LON:0QND)

Market Cap	3.97B
Revenue (ttm)	533.52M
Net Income (ttm)	105.99M
Shares Out	n/a
EPS (ttm)	1.41
PE Ratio	37.47
Forward PE	34.75
Dividend	0.78 (1.35%)
Ex-Dividend Date	May 5, 2025

Volume	18,572
Average Volume	11,721
Open	57.00
Previous Close	57.50
Day's Range	55.98 - 57.40
52-Week Range	43.98 - 90.20
Beta	1.01
RSI	66.43
Earnings Date	Jul 24, 2025

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1971
• Employees: 2,207
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QND

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.

Financial numbers in CHF